insights_auto
Pse është rritur ALTME 12,32%?
Zhytu më thellëchevron_right
ALTME:EPA
TME Pharma NV
0,12 €
arrow_upward
+12,32%(+0,014) 1D
23 tet, 5:35:11 m.d., GMT+2 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për ALTME...
Hap
0,11 €
I lartë
0,13 €
I ulët
0,11 €
Kapitalizimi i tregut
11,25 mln
Vëllimi mesatar
1,47 mln
Vëllimi
2,45 mln
Maksimumi 52-javor
0,17 €
Minimumi 52-javor
0,05 €
Fitimet për aksion
-0,03 €
Numri i punonjësve
0
Hap
0,11 €
I lartë
0,13 €
I ulët
0,11 €
Kapitalizimi i tregut
11,25 mln
Vëllimi mesatar
1,47 mln
Vëllimi
2,45 mln
Maksimumi 52-javor
0,17 €
Minimumi 52-javor
0,05 €
Fitimet për aksion
-0,03 €
Numri i punonjësve
0
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Endpoints News
·
28 minuta më parë
Swiss biotech Windward Bio files for Nasdaq IPO to fund China-derived assets and in-house R&D
01net
·
40 minuta më parë
Stem Announces Notification of Noncompliance with NYSE Continued Listing Standards
Yahoo Finance
·
1 orë më parë
S&P 500, Dow Drop As Elevated Oil Prices Stoke Inflation Fears Ahead Of Fed Meeting Next Week — AAPL, AXP, CART, UBER In Focus
CNBC
·
7 orë më parë
The S&P 500 is forming a bearish chart pattern. Can it snap out of it?
Profili
TME Pharma, formerly NOXXON Pharma, is a biotechnology company founded in 1997 in Berlin, Germany which specialises on cancer treatment by targeting the tumor microenvironment. TME Pharma N.V. is listed on Euronext Growth, Paris and is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller.
TME Pharma develops drugs using technology yielding L-RNA molecules, which are of mirror-image configuration compared to naturally occurring D-RNA molecules. The company calls these agents Spiegelmers, from Spiegel, the German word for "mirror."
The L-RNA are resistant to the natural RNA nuclease enzymes. Wikipedia
Rreth TME Pharma NV